Fungal KATs/KDACs: A New Highway to Better Antifungal Drugs?
Department of Medical Biochemistry, Medical University Vienna, Max F. Perutz Laboratories, Austria.
Karl
0000-0003-2719-5955
K
Kuchler
Department of Medical Biochemistry, Medical University Vienna, Max F. Perutz Laboratories, Austria.
Sabrina
S
Jenull
Department of Medical Biochemistry, Medical University Vienna, Max F. Perutz Laboratories, Austria.
Raju
R
Shivarathri
Public Health Research Institute.|Department of Microbiology, Biochemistry and Molecular Genetics, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark.
Neeraj
0000-0002-9252-9897
N
Chauhan
D000818:Animals; D000935:Antifungal Agents / Q000627:therapeutic use*; D002176:Candida albicans / Q000201:enzymology; D005656:Fungal Proteins / Q000378:metabolism*; D056466:Histone Demethylases / Q000378:metabolism*; D054884:Host-Pathogen Interactions / Q000502:physiology; D006801:Humans; D000070837:Lysine Acetyltransferases / Q000378:metabolism*; D009181:Mycoses / Q000378:metabolism*
D000935:Antifungal Agents; D005656:Fungal Proteins; D056466:Histone Demethylases; D000070837:Lysine Acetyltransferases